Biora Therapeutics Announces New Patents for Targeted Therapeutics Platform
Marks 29 Patents Worldwide Directed to Biora’s Device Localization TechnologySAN DIEGO, May 19, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc....
Day: May 19, 2022
NeuroMetrix Reports that Quell® Wearable Neuromodulation Device has Received FDA De Novo Authorization as First Non-Pharmacological Treatment for Fibromyalgia
WOBURN, Mass., May 19, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced U.S. Food and Drug Administration (FDA)...
National Research Corporation Announces Appointment to Board of Directors
Microsoft Executive Parul Bhandari Brings Digital Transformation Expertise to BoardLINCOLN, Neb., May 19, 2022 (GLOBE NEWSWIRE) -- National Research Corporation,...
Groundbreaking Headlands Research and Pfizer Partnership to Significantly Improve Diversity in Clinical Trials
SAN FRANCISCO, May 19, 2022 (GLOBE NEWSWIRE) -- Headlands Research, a leading international network of clinical trial sites, announced today...
Smart for Life to Present at the H.C. Wainwright Global Investment Conference on May 25th
MIAMI, May 19, 2022 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a...
Rafael Pharmaceuticals, Inc. Announces Corporate Name Change to Cornerstone Pharmaceuticals, Inc.
Company name change reflects mission to address significant unmet needs in rare cancer therapeutics, returning to company rootsCranbury, NJ, May...
Mustang Bio Announces Updated Interim Data on X-Linked Severe Combined Immunodeficiency Treatment with Lentiviral Vector Gene Therapy Support Upcoming Multicenter Pivotal Phase 2 Trial for MB-107
All 23 treated patients are alive at 2.6-year median follow-up without evidence of malignant transformation Data representing largest cohort of...
Accelus Receives U.S. FDA 510(k) Clearance for its Toro-L Interbody Fusion System
Toro Lateral (Toro-L) Interbody Fusion System Accelus announced today that it had received U.S. FDA 510(k) Clearance for its Toro-L...
Yield10 Bioscience to Present at the H.C. Wainwright Global Hybrid Investment Conference
WOBURN, Mass., May 19, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN) (“Yield10” or the “Company”), an agricultural bioscience...
Helsinn appoints Dr Melanie Rolli as Group Chief Operating Officer
Helsinn appoints Dr Melanie Rolli as Group Chief Operating Officer Lugano, Switzerland, May 19, 2022 – Helsinn Group, a fully...
Kane Biotech to Release First Quarter 2022 Financial Results on May 26 – Conference Call to Follow
WINNIPEG, Manitoba, May 19, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a...
Checkpoint Therapeutics to Participate in the H.C. Wainwright Global Investment Conference
WALTHAM, Mass., May 19, 2022 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology...
Vaxart Announces the Publication of Studies in the Peer-Reviewed Journal Science Translational Medicine That Suggest Mucosal Immunization Could Decrease SARS-CoV-2 Transmission
A preclinical study in hamsters showed both a decrease in infectious virus and in transmission Phase 1 data measuring cross-reactivity also...
Tricida Announces Administrative Stop of the VALOR-CKD Trial
Expects to Announce Top-Line Results Early in the Fourth Quarter of 2022SOUTH SAN FRANCISCO, Calif., May 19, 2022 (GLOBE NEWSWIRE)...
TOMI CEO Dr. Halden Shane to Present at the H.C. Wainwright Global Investment Conference
FREDERICK, Md., May 19, 2022 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ:TOMZ), a global company specializing in disinfection...
WIMI Hologram Academy: Virtual Reality Technology Provides An Immersive Recovery Experience
HONG KONG, May 19, 2022 (GLOBE NEWSWIRE) -- WIMI Hologram Academy, working in partnership with the Holographic Science Innovation Center,...
Allogene Therapeutics Announces Oral Presentation of Pre-Clinical Data Highlighting Improved Anti-Tumor Activity of Donor-Derived Allogeneic CAR T Cells at American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
Cells Derived from Healthy, Younger Donors were More Abundant with Greater Fitness and Cancer Killing Potential Than Cells Derived from...
Vyant Bio to Present at the H.C. Wainwright Global Investment Hybrid Conference
Cherry Hill, N.J., May 19, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT), is an...
Amarin Announces Appointment of New Directors and Board Leadership Changes
Erin Enright and Alfonso “Chito” Zulueta Appointed to Board of Directors New Board Members Bring Skills and Experience Aligned with...
Shockwave IVL Maintains Superiority to Angioplasty in Calcified Peripheral Disease at Two Years
Randomized Disrupt PAD III Study Finds Superior Vessel Preparation Leads to Excellent Long-Term Outcomes and Preserved Future Treatment OptionsSANTA CLARA,...